Copyright medicaldialogues
Here are the top medical news for the day:Dietary habits linked to Parkinson’s risk: sweets, processed meats raise risk, fruit lowers them, Study finds Scientists have identified specific dietary patterns that may influence the risk of Parkinson’s disease (PD), a neurodegenerative disorder affecting movement and quality of life. A recent case-control study published in the Journal of Parkinson’s Disease examined how clusters of foods consumed by Italians relate to PD risk, comparing these dietary factors with established non-dietary contributors. The findings suggest that frequent intake of sweets, red meat, and cured meats increases PD risk, while fruit consumption, particularly citrus, appears protective.Parkinson’s disease has been linked to oxidative stress and inflammation damaging brain neurons, and diet could be a significant modifiable factor. Prior studies focusing on individual foods or predefined diets like Mediterranean or DASH have yielded inconsistent results. This study used data-driven analysis to identify dietary patterns specific to the Italian population that may better reveal associations with PD risk. Researchers conducted a retrospective case-control study with 680 PD patients and 612 matched controls recruited from six Italian neurology centers. Dietary intake was assessed using a 77-item Food Frequency Questionnaire reflecting typical Italian foods consumed before PD symptoms. Non-dietary factors—such as pesticide exposure, smoking, coffee consumption, and family history—were also collected. Principal Component Analysis and Exploratory Factor Analysis identified seven distinct dietary patterns. Logistic regression models adjusted for demographic and environmental factors tested associations between these patterns and PD risk. The analysis showed that higher consumption of sweets (OR 1.20), red meat (OR 1.15), and cured meats (OR 1.32) was significantly associated with greater odds of PD. Conversely, fruit intake lowered PD odds (OR 0.84), with citrus fruits driving this protective effect. Non-dietary factors such as pesticide exposure and family history exerted even stronger risk influences, while coffee and smoking were protective. Physical activity’s protective effects were confounded by correlated unhealthy dietary habits. These results point to practical dietary adjustments—reducing sweets and processed meats while increasing fruit—that may complement other known PD risk reduction strategies. Lead researchers highlighted the need for prospective and diverse-population studies to confirm causality and generalize findings, but the study offers actionable insights for PD prevention through diet modification. REFERENCE: Gigante, A. F., Vitucci, B., Velucci, V., Pellicciari, R., Modugno, N., Pietracupa, S., De Bartolo, M. I., Costanzo, M., Terravecchia, C., Mascia, M. M., Muroni, A., Ercoli, T., Solla, P., Magrinelli, F., Conte, A., Fabbrini, G., Nicoletti, A., Tinazzi, M., Berardelli, A., Defazio, G., & Belvisi, D. (2025). The impact of diet on Parkinson’s disease risk: A data-driven analysis in a large Italian case-control population. Journal of Parkinson’s Disease. DOI: 10.1177/1877718X251388058 Scientists discover hidden antibiotic 100 times stronger against superbugs Chemists from the University of Warwick and Monash University have discovered a potent new antibiotic that targets drug-resistant bacteria, including Methicillin-resistant Staphylococcus aureus (MRSA) and Vancomycin-resistant Enterococcus (VRE). Published recently in the Journal of the American Chemical Society, this compound, called pre-methylenomycin C lactone, was found "hiding in plain sight" as an intermediate during the natural biosynthesis of the older antibiotic methylenomycin A.Antimicrobial resistance (AMR) poses a critical global health threat, with millions of deaths annually due to antibiotic-resistant infections. However, the development of new antibiotics has slowed, partly because discovery is challenging and financially unrewarding. This team’s breakthrough offers renewed hope by identifying a previously overlooked chemical intermediate with extraordinary antibacterial activity—over 100 times more potent against Gram-positive bacteria than methylenomycin A. The researchers deleted biosynthetic genes in Streptomyces coelicolor, a well-studied soil bacterium known for producing methylenomycin A, to isolate and characterize two new intermediate compounds. These intermediates were then tested for antimicrobial activity against various drug-resistant pathogens, including the bacteria responsible for MRSA and VRE. The compound's potency and resistance profile were examined through laboratory assays, particularly assessing the likelihood of resistance development. Pre-methylenomycin C lactone demonstrated exceptional efficacy, showing a 100-fold increase in activity against Gram-positive bacteria compared to methylenomycin A. Notably, no resistance emerged in Enterococcus faecium after prolonged...
